CRCA vs. XTJL

Last updated Jun 24, 2026

CRCA (ProShares Ultra CRCL) and XTJL (Innovator U.S. Equity Accelerated Plus ETF - July) are both Leveraged Equities funds. Both are actively managed. At a 0.43 correlation, their price movements are largely independent. CRCA charges 0.95%/yr vs 0.79%/yr for XTJL.

Performance

CRCA vs. XTJL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares Ultra CRCL (CRCA) and Innovator U.S. Equity Accelerated Plus ETF - July (XTJL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CRCA achieves a -50.19% return, which is significantly lower than XTJL's 5.60% return.

CRCA

• 1D: -10.71%
• 1M: -58.97%
• YTD: -50.19%
• 6M: -54.34%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

XTJL

• 1D: -0.06%
• 1M: 0.45%
• YTD: 5.60%
• 6M: 5.32%
• 1Y: 14.52%
• 3Y*: 14.41%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CRCA vs. XTJL - Yearly Performance Comparison

	2026 (YTD)	2025
CRCA ProShares Ultra CRCL	-50.19%	-84.67%
XTJL Innovator U.S. Equity Accelerated Plus ETF - July	5.60%	6.06%

Correlation

The correlation between CRCA and XTJL is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Aug 7, 2025	0.43

Return for Risk

CRCA vs. XTJL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRCA

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

XTJL

XTJL Risk / Return Rank: 72
XTJL Sharpe Ratio Rank: 65
XTJL Sortino Ratio Rank: 71
XTJL Omega Ratio Rank: 80
XTJL Calmar Ratio Rank: 62
XTJL Martin Ratio Rank: 84

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRCA vs. XTJL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and Innovator U.S. Equity Accelerated Plus ETF - July (XTJL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CRCA	XTJL	Difference
Sharpe ratio: Return per unit of total volatility	—	1.98	—
Sortino ratio: Return per unit of downside risk	—	2.95	—
Omega ratio: Gain probability vs. loss probability	—	1.44	—
Calmar ratio: Return relative to maximum drawdown	—	2.85	—
Martin ratio: Return relative to average drawdown	—	16.13	—

Drawdowns

CRCA vs. XTJL - Drawdown Comparison

The maximum CRCA drawdown since its inception was -94.31%, which is greater than XTJL's maximum drawdown of -23.24%. Use the drawdown chart below to compare losses from any high point for CRCA and XTJL.

Drawdown Indicators

	CRCA	XTJL	Difference
Max Drawdown Largest peak-to-trough decline	-94.31%	-23.24%	-71.07%
Max Drawdown (1Y) Largest decline over 1 year	—	-5.12%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-16.70%	—
Current Drawdown Current decline from peak	-92.37%	-0.06%	-92.31%
Average Drawdown Average peak-to-trough decline	-71.73%	-4.00%	-67.73%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	0.90%	—

Volatility

Volatility by Period

	CRCA	XTJL	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	0.36%	—
Volatility (6M) Calculated over the trailing 6-month period	—	5.65%	—
Volatility (1Y) Calculated over the trailing 1-year period	194.67%	7.35%	+187.32%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	194.67%	15.14%	+179.53%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	194.67%	15.14%	+179.53%

CRCA vs. XTJL - Expense Ratio Comparison

CRCA has a 0.95% expense ratio, which is higher than XTJL's 0.79% expense ratio.

Dividends

CRCA vs. XTJL - Dividend Comparison

CRCA's dividend yield for the trailing twelve months is around 3.48%, while XTJL has not paid dividends to shareholders.

Position	TTM	2025
CRCA ProShares Ultra CRCL	3.48%	1.06%
XTJL Innovator U.S. Equity Accelerated Plus ETF - July	0.00%	0.00%

Frequently Asked Questions

Can I hold both CRCA and XTJL in my portfolio?

CRCA and XTJL have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, CRCA or XTJL?

On fees, XTJL is cheaper at 0.79% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CRCA or XTJL?

XTJL is cheaper with a 0.79% expense ratio, compared with 0.95% for CRCA.

Which ETF pays a higher dividend yield, CRCA or XTJL?

CRCA has the higher dividend yield at 3.48%, compared with 0.00% for XTJL.

What is the main difference between CRCA and XTJL?

They also come from different issuers: ProShares and Innovator. Their fees differ too: 0.95% for CRCA and 0.79% for XTJL.